PlainRecalls
FDA Devices Moderate Class II Terminated

Tosoh ST AIA-PACK HbA1c Control, HbA1c Control, PN 025418 The product is intended for In Vitro Diagnostic Use Only for performing quality control procedures with the HbA1c Assay.

Reported: May 23, 2018 Initiated: March 5, 2018 #Z-1811-2018

Product Description

Tosoh ST AIA-PACK HbA1c Control, HbA1c Control, PN 025418 The product is intended for In Vitro Diagnostic Use Only for performing quality control procedures with the HbA1c Assay.

Reason for Recall

The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.

Details

Recalling Firm
Tosoh Bioscience Inc
Units Affected
2864
Distribution
USA (nationwide) Distribution including PR and to the states of : AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MO, NC, NE, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY.
Location
Grove City, OH

Frequently Asked Questions

What product was recalled?
Tosoh ST AIA-PACK HbA1c Control, HbA1c Control, PN 025418 The product is intended for In Vitro Diagnostic Use Only for performing quality control procedures with the HbA1c Assay.. Recalled by Tosoh Bioscience Inc. Units affected: 2864.
Why was this product recalled?
The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 23, 2018. Severity: Moderate. Recall number: Z-1811-2018.